Synthesis and evaluation of [18F]-FEAnGA as a PET tracer for β-glucuronidase activity

Bioconjugate Chemistry

Volumn 21, Issue 5, 2010, Pages 911-920

  Antunes, Inês F ^a   Haisma, Hidde J ^a   Elsinga, Philip H ^a   Dierckx, Rudi A ^a   De Vries, Erik F J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 FLUOROETHYLAMINE GLUCURONIC ACID F 18; BETA GLUCURONIDASE; CARBAMIC ACID; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; IMIDAZOLE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; SODIUM HYDROXIDE; SODIUM PEROXIDE; SUGAR; UNCLASSIFIED DRUG; 2 FLUOROETHYLAMINE; 2-FLUOROETHYLAMINE; DIAGNOSTIC AGENT; ETHYLAMINE; GLUCURONIC ACID;

ALKYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE; CELL STRAIN C6; CELL STRAIN CT26; COLON ADENOCARCINOMA; CONTROLLED STUDY; DEPROTECTION REACTION; DRUG RELEASE; DRUG RETENTION; DRUG SCREENING; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; ENZYME ACTIVITY; ENZYME SYNTHESIS; ESCHERICHIA COLI; GLIOMA CELL; HUMAN; HUMAN CELL; HYDROPHILICITY; IN VITRO STUDY; LIVER; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; RADIOCHEMISTRY; ADENOCARCINOMA; ANIMAL; CATTLE; CHEMISTRY; COLON TUMOR; ENZYMOLOGY; GLIOMA; METABOLISM; METHODOLOGY; NEOPLASM; RAT; SYNTHESIS; TUMOR CELL LINE;

BOVINAE; ESCHERICHIA COLI; MURINAE; MUS; RATTUS;

ADENOCARCINOMA; ANIMALS; CATTLE; CELL LINE, TUMOR; COLONIC NEOPLASMS; ESCHERICHIA COLI; ETHYLAMINES; GLIOMA; GLUCURONIC ACID; GLUCURONIDASE; HUMANS; MICE; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS;

EID: 77952563299     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc9004602     Document Type: Article

References (33)

1. de Graaf, M., Boven, E., Scheeren, H. W., Haisma, H. J., and Pinedo, H. M. (2002) Beta-glucuronidase-mediated drug release Curr. Pharm. Des. 8, 1391-1403
2. George, J. (2008) Elevated serum beta-glucuronidase reflects hepatic lysosomal fragility following toxic liver injury in rats Biochem. Cell Biol. 86, 235-243
3. Boyer, M. J. and Tannock, I. F. (1993) Lysosomes, lysosomal enzymes, and cancer Adv. Cancer Res. 60, 269-291
4. Chen, X., Wu, B., and Wang, P. G. (2003) Glucuronides in anti-cancer therapy Curr. Med. Chem. Anticancer Agents 3, 139-150
5. de Groot, F. M., Damen, E. W., and Scheeren, H. W. (2001) Anticancer prodrugs for application in monotherapy: targeting hypoxia, tumor-associated enzymes, and receptors Curr. Med. Chem. 8, 1093-1122
6. Denny, W. A. (2003) Prodrugs for gene-directed enzyme-prodrug therapy (suicide gene therapy) J. Biomed. Biotechnol. 48-70
7. Papot, S., Tranoy, I., Tillequin, F., Florent, J. C., and Gesson, J. P. (2002) Design of selectively activated anticancer prodrugs: elimination and cyclization strategies Curr. Med. Chem. Anticancer Agents 2, 155-185
8. Rivault, F., Tranoy-Opalinski, I., and Gesson, J. P. (2004) A new linker for glucuronylated anticancer prodrugs Bioorg. Med. Chem. 12, 675-682
9. Sperker, B., Murdter, T. E., Schick, M., Eckhardt, K., Bosslet, K., and Kroemer, H. K. (1997) Interindividual variability in expression and activity of human beta-glucuronidase in liver and kidney: consequences for drug metabolism J. Pharmacol. Exp. Ther. 281, 914-920
10. Sperker, B., Werner, U., Murdter, T. E., Tekkaya, C., Fritz, P., Wacke, R., Adam, U., Gerken, M., Drewelow, B., and Kroemer, H. K. (2000) Expression and function of beta-glucuronidase in pancreatic cancer: potential role in drug targeting Naunyn Schmiedebergs Arch. Pharmacol. 362, 110-115
11. Chen, K. C., Cheng, T. L., Leu, Y. L., Prijovich, Z. M., Chuang, C. H., Chen, B. M., and Roffler, S. R. (2007) Membrane-localized activation of glucuronide prodrugs by beta-glucuronidase enzymes Cancer Gene Ther. 14, 187-200
12. Ho, N. H., Weissleder, R., and Tung, C. H. (2007) A self-immolative reporter for beta-galactosidase sensing ChemBioChem 8, 560-566
13. Su, Y. C., Chuang, K. H., Wang, Y. M., Cheng, C. M., Lin, S. R., Wang, J. Y., Hwang, J. J., Chen, B. M., Chen, K. C., Roffler, S., and Cheng, T. L. (2007) Gene expression imaging by enzymatic catalysis of a fluorescent probe via membrane-anchored beta-glucuronidase Gene Ther. 14, 565-574
14. Biber, F. Z., Unak, P., Ertay, T., Medine, E. I., Zihnioglu, F., Tasci, C., and Durak, H. (2006) Synthesis of an estradiol glucuronide derivative and investigation of its radiopharmaceutical potential Appl. Radiat. Isot. 64, 778-788
15. Celen, S., Deroose, C., de Groot, T., Chitneni, S. K., Gijsbers, R., Debyser, Z., Mortelmans, L., Verbruggen, A., and Bormans, G. (2008) Synthesis and evaluation of F-18- and C-11-labeled phenyl-galactopyranosides as potential probes for in vivo visualization of LacZ gene expression using positron emission tomography Bioconjugate Chem. 19, 441-449
16. Ertay, T., Unak, P., Biber, F. Z., Tasci, C., Zihnioglu, F., and Durak, H. (2007) Scintigraphic imaging with a peptide glucuronide in rabbits: Tc-99m-exorphin C glucuronide Appl. Radiat. Isot. 65, 170-175
17. Kumar, P., Wiebe, L. I., Mannan, R. H., Zhang, Z., Xia, H. Y., and Mcewan, A. J. (2002) [Tc-99m]Technetium labelled PnAo-azomycin glucuronides: a novel class of imaging markers of tissue hypoxia Appl. Radiat. Isot. 57, 719-728
18. Brady, F., Luthra, S. K., Brown, G. D., Osman, S., Aboagye, E., Saleem, A., and Price, P. M. (2001) Radiolabelled tracers and anticancer drugs for assessment of therapeutic efficacy using PET Curr. Pharm. Des. 7, 1863-1892
19. Rukhman, I. and Gutman, A. L. (2000) Synthesis of morphine 6-alpha-D-glucuronide Tetrahedron Lett. 41, 6889-6892
20. Antunes, I. F., Haisma, H. J., and de Vries, E. F. (2008) Tumor-specific activation of prodrugs: is there a role for nuclear medicine? Nucl. Med. Commun. 29, 845-846
21. Duimstra, J. A., Femia, F. J., and Meade, T. J. (2005) A gadolinium chelate for detection of beta-glucuronidase: A self-immolative approach J. Am. Chem. Soc. 127, 12847-12855
22. Tewson, T. J. (1997) Synthesis of [F-18]fluoroetanidazole: A potential new tracer for imaging hypoxia Nucl. Med. Biol. 24, 755-760
23. Combaud, D., Thomas, M., Papot, S., and Gesson, J. P. (2005) Synthesis and evaluation of p-nitrophenyl beta-D-glucopyranosiduronic analogues as new triggers for beta-glucuronidase mediated prodrug monotherapy Lett. Drug Des. Discovery 2, 631-637
24. Tomasic, J. and Keglevic, D. (1973) Kinetics of hydrolysis of synthetic glucuronic esters and glucuronic ethers by bovine liver and Escherichia-coli beta-glucuronidase Biochem. J. 133, 789-795
25. Chittaboina, S., Hodges, B., and Wang, Q. (2006) A facile route for the regioselective deacetylation of peracetylated carbohydrates at anomeric position Lett. Org. Chem. 3, 35-38
26. Stachulski, A. V. and Jenkins, G. N. (1998) The synthesis of O-glucuronides Nat. Prod. Rep. 15, 173-186
27. Houba, P. H., Leenders, R. G., Boven, E., Scheeren, J. W., Pinedo, H. M., and Haisma, H. J. (1996) Characterization of novel anthracycline prodrugs activated by human beta-glucuronidase for use in antibody-directed enzyme prodrug therapy Biochem. Pharmacol. 52, 455-463
28. Huwyler, J., Drewe, J., Klusemann, C., and Fricker, G. (1996) Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium Br. J. Pharmacol. 118, 1879-1885
29. Huwyler, J., Drewe, J., Gutmann, H., Thole, M., and Fricker, G. (1998) Modulation of morphine-6-glucuronide penetration into the brain by P-glycoprotein Int. J. Clin. Pharmacol. Ther. 36, 69-70
30. Leu, Y. L., Chen, C. S., Wu, Y. J., and Chern, J. W. (2008) Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy J. Med. Chem. 51, 1740-1746
31. Bosslet, K., Czech, J., and Hoffmann, D. (1994) Tumor-selective prodrug activation by fusion protein-mediated catalysis Cancer Res. 54, 2151-2159
32. Wei, G. P., Loktionova, N. A., Pegg, A. E., and Moschel, R. C. (2005) beta-glucuronidase-cleavable prodrugs of O-6-benzylguanine and O-6-benzyl-2 ′-deoxyguanosine J. Med. Chem. 48, 256-261
33. Bakina, E., Wu, Z., Rosenblum, M., and Farquhar, D. (1997) Intensely cytotoxic anthracycline prodrugs: glucuronides J. Med. Chem. 40, 4013-4018